91高清自产国产拍,无码免费A级毛片大全,日本 欧美 国产中文字幕,99re热视频这里只有精品视频首页

丁苯羟酸

HDAC6和HDAC10抑制剂。NSAID。
规格或纯度: ≥98.0%(HPLC)
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
B129286-1g
1g 现货 Stock Image
B129286-5g
5g 现货 Stock Image
B129286-25g
25g 现货 Stock Image
B129286-100g
100g 现货 Stock Image

基本描述

规格或纯度 ≥98.0%(HPLC)
英文名称 Bufexamac
别名 丁苯羟酸
英文别名 bufexamac|2438-72-4|Bufexamic acid|2-(4-Butoxyphenyl)-N-hydroxyacetamide|Parfenac|Droxaryl|Feximac|Malipuran|Mofenar|Norfemac|Paraderm|Parfenal|Anderm|4-Butoxy-N-hydroxybenzeneacetamide|Bufexamaco|Bufexamacum|Flogicid|p-Butoxyphenylacetohydroxamic acid|4-
生化机理 Bufexamac is a specific inhibitor of HDAC6 and HDAC10. Treatment of peripheral blood mononuclear cells with bufexamac inhibits the secretion of IFN-α. Bufexamac is a frequent and relevant contact sensitizer.HDAC6 and HDAC10 inhibitor. NSAID. COX inhibitor for IFN-α release (EC 50 = 9 μM). Shows anti-inflammatory, analgesic, and antipyretic effects in vivo. Orally active.
应用 A HDAC6 and HDAC10 inhibitor.
运输条件 常规运输
备注 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。
产品介绍

Bufexamac是一种环氧酶抑制剂,靶点是IFN-α, EC50 为8.9 μM。A HDAC6 and HDAC10 inhibitor.

Bufexamac is a COX inhibitor for IFN-α release with EC50 of 8.9 μM.
A HDAC6 and HDAC10 inhibitor.

名称和标识符

EC号 219-451-1
IUPAC Name 2-(4-butoxyphenyl)-N-hydroxyacetamide
INCHI InChI=1S/C12H17NO3/c1-2-3-8-16-11-6-4-10(5-7-11)9-12(14)13-15/h4-7,15H,2-3,8-9H2,1H3,(H,13,14)
InChi Key MXJWRABVEGLYDG-UHFFFAOYSA-N
Canonical SMILES CCCCOC1=CC=C(C=C1)CC(=O)NO
分子式

C12H17NO3

PubChem CID 2466
分子量 223.27

化学和物理性质

溶解性 DMSO 45 mg/mL Water Ethanol 3 mg/mL
熔点 164 °C(dec.)

安全信息

象形图
ghs07

Harmful

信号词 Warning
危险声明 H302: Harmful if swallowed
H317: May cause an allergic skin reaction
预防措施声明 P261,P280,P302+P352,P321,P501,P264,P270,P272,P333+P313,P362+P364,P330,P301+P317
RTECS AK8280000
Reaxy-Rn 2646848
Merck Index 1474

靶标

Target ID 2614
名称 histone deacetylase 10
缩写名 SHP2
家族 3.5.1.- Histone deacetylases (HDACs)
别名 EP2
基因和蛋白信息
Species Transmembrane Domains Amino Acids Chromosomal Location Gene Symbol Gene Name
Human 2 669 22q13.33 HDAC10 histone deacetylase 10
Mouse 2 666 15 E3 Hdac10 histone deacetylase 10
Rat 2 588 7q34 Hdac10 histone deacetylase 10
Entrez Gene 83933 (Hs) , 170787 (Mm) , 362981 (Rn)
UniProtKB Q569C4 (Rn) , Q6P3E7 (Mm) , Q969S8 (Hs)
Ensembl Gene ENSG00000100429 (Hs) , ENSMUSG00000062906 (Mm) , ENSRNOG00000031915 (Rn)
RefSeq Nucleotide NM_001035000 (Rn) , NM_032019 (Hs) , NM_199198 (Mm)
RefSeq Protein NP_001030172 (Rn) , NP_114408 (Hs) , NP_954668 (Mm)
OMIM 608544 (Hs)
Protein GI 20070354 (Hs) , 259089444 (Mm) , 211065499 (Rn)
CATH/Gene3D 3.40.800.20 (N/A)
ChEMBL Target CHEMBL5103 (Hs)
Target ID 2618
名称 histone deacetylase 6
缩写名 SHP2
家族 3.5.1.- Histone deacetylases (HDACs)
别名 EP2
基因和蛋白信息
Species Transmembrane Domains Amino Acids Chromosomal Location Gene Symbol Gene Name
Human 2 1215 Xp11.23 HDAC6 histone deacetylase 6
Mouse 2 1149 X 3.58 cM Hdac6 histone deacetylase 6
Rat 2 147 Xq13 Hdac6 histone deacetylase 6
Entrez Gene 10013 (Hs) , 15185 (Mm) , 84581 (Rn)
UniProtKB Q9UBN7 (Hs) , Q9Z2V5 (Mm)
Ensembl Gene ENSG00000094631 (Hs) , ENSMUSG00000031161 (Mm) , ENSRNOG00000048738 (Rn)
RefSeq Nucleotide NM_006044 (Hs) , NM_010413 (Mm)
RefSeq Protein NP_006035 (Hs) , NP_034543 (Mm)
OMIM 300272 (Hs)
Orphanet 248481 (Hs)
Protein GI 13128864 (Hs) , 194353997 (Mm)
DrugBank Target Q9UBN7 (Hs)
CATH/Gene3D 3.30.40.10 (N/A) , 3.40.800.20 (N/A)
ChEMBL Target CHEMBL2878 (Mm) , CHEMBL1865 (Hs)

关联配体

Ligand ID 7498
名称 bufexamac
别名 CP-1044-J3
类别 Synthetic organic
学名 2-(4-butoxyphenyl)-N-hydroxyacetamide
生物活性评价 The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in ).
评价 In addition to inhibition of COX enzymes, this drug has been discovered to inhibit class IIb HDACs (ie HDACs 6 and 10) .
配体家族 Non-steroidal anti-inflammatory ligands

参考文献

1. Trommer H, Pl?tzer M, Raith K, Wohlrab W, Podhaisky HP, Neubert RH.  (2003)  Examinations of the antioxidative properties of the topically administered drug bufexamac reveal new insights into its mechanism of action..  J Pharm Pharmacol,  55  (10):  (1379-88).  [PMID:14607020]
2. Bantscheff M, Hopf C, Savitski MM, Dittmann A, Grandi P, Michon AM, Schlegl J, Abraham Y, Becher I, Bergamini G et al..  (2011)  Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes..  Nat Biotechnol,  29  (3):  (255-65).  [PMID:21258344]

产品问答

产品问答

登录提交问题 Hover me 请先登录再提交问题
您提交该产品问题后,我们会在1-2个工作日内给您答复,您可以登录"我的账号",然后点击"我的产品问答"查看答案

91高清自产国产拍,无码免费A级毛片大全,日本 欧美 国产中文字幕,99re热视频这里只有精品视频首页

品牌简介

{转码主词}